Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes

Leukemia & Lymphoma
G FinazziJ J Michiels

Abstract

Bleeding time (BT) and platelet function tests have been widely used in patients with essential thrombocythemia (ET), with the aim to support diagnosis and to identify laboratory predictors of haemorrhagic and thrombotic complications. BT is significantly prolonged in 7-19% of ET patients and several functional abnormalities have been observed in platelet structure, biochemistry and survival. However, the attempt to relate these in vivo and in vitro platelet dysfunctions with diagnosis or clinical sequelae has been generally disappointing. Therefore, BT and platelet function tests are currently not recommended in the initial evaluation or during the follow-up of patients with ET, unless in the setting of a clinical or biological study. A noteworthy exception is represented by a subset of patients characterized by very high platelet count (> 1500 x 10(9)/L) and bleeding symptoms, who can have an acquired von Willebrand disease. In these cases, prolonged BT and abnormal multimeric pattern of von Willebrand factor are useful for diagnosing and monitoring this acquired hemorrhagic disease. BT and platelet function tests should be included in the baseline evaluation of ET patients enrolled in prospective clinical trials aiming asses...Continue Reading

References

Aug 1, 1978·Archives of Internal Medicine·S MurphyF H Gardner
Apr 1, 1975·Annals of Internal Medicine·A D Ginsburg
Feb 1, 1991·Thrombosis Research·A WehmeierW Schneider
Jan 1, 1991·American Journal of Clinical Pathology·C L BalduiniG C Piletta
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S CortelazzoT Barbui
Aug 1, 1990·Cancer·P FenauxF Bauters
Jan 1, 1990·Seminars in Thrombosis and Hemostasis·R P Rodgers, J Levin
Nov 1, 1989·European Journal of Haematology·E Löfvenberg, T K Nilsson
Mar 1, 1988·Klinische Wochenschrift·B BaumannR Hehlmann
Mar 1, 1989·British Journal of Haematology·J M DudleyT C Pearson
Feb 1, 1986·Prostaglandins, Leukotrienes, and Medicine·M R BuchananD J Nazir
Oct 1, 1988·American Journal of Clinical Pathology·E SehayekD Meytes
Nov 1, 1987·American Journal of Clinical Pathology·J J MichielsJ Abels
Feb 1, 1985·Scandinavian Journal of Haematology·S CortellazzoG de Gaetano
Jan 1, 1974·Scandinavian Journal of Haematology·T AdamsL Goldberg
Mar 1, 1972·American Journal of Clinical Pathology·J A NeemehC A Owen
May 1, 1966·American Journal of Clinical Pathology·P Didisheim, D Bunting
Feb 18, 1982·The New England Journal of Medicine·A I Schafer
Apr 1, 1981·The Journal of Clinical Investigation·A Moore, R L Nachman
Jan 1, 1994·Scandinavian Journal of Rheumatology·A J GeirssonL P Asgeirsdóttir
Aug 1, 1993·Annals of Hematology·P J van Genderen, J J Michiels

❮ Previous
Next ❯

Citations

May 25, 2001·International Journal of Hematology·G H Goldsmith
Nov 15, 2002·International Journal of Hematology·Tiziano Barbui
May 23, 1998·Blood Reviews·S Willoughby, T C Pearson
May 5, 1999·Critical Reviews in Oncology/hematology·T Barbui, G Finazzi
May 24, 2003·Best Practice & Research. Clinical Haematology·Michelle A Elliott, Ayalew Tefferi
Jun 13, 2002·British Journal of Haematology·Claire N Harrison
Nov 19, 2015·Expert Review of Hematology·Ulrich BuddeRita Dittmer
Oct 10, 2014·Thrombosis and Haemostasis·C StrasselF Lanza
Jul 18, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M S LagunaF C Molinas
Mar 6, 2016·Journal of Hematology & Oncology·A KaifieUNKNOWN Study Alliance Leukemia (SAL)
Aug 13, 2011·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Argirios E TsantesGeorgios Mantzios
Dec 13, 2007·Bulletin de l'Académie nationale de médecine·Sylvia Bellucci
Sep 10, 2019·Journal of Medical Biochemistry·Aysun Şentürk Yıkılmazİmdat Dilek
Feb 11, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Grażyna GadomskaRadosław Wieczór
Jan 1, 1997·Hematology·T BarbuiT C Pearson
Oct 6, 2001·The Clinical Journal of Pain·C McCrory, D Westerling

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.